A short clinical answer should preserve the population, comparison, important outcomes, size of the effect and uncertainty that make the evidence interpretable. Removing those details can change the answer rather than merely shorten it. Cochrane Clinical Answers provides a useful reference point for examining that problem because it is a named product built around concise, review-linked clinical questions.
As described in Cochrane's product information, checked on 26 September 2026, Cochrane Clinical Answers connects clinically focused questions and concise answers with evidence from Cochrane Reviews. It should not be confused with every plain-language summary or every abstract published in the wider Cochrane Library.
This comparison is published by iatroX and includes iatroX among the reference tools considered. No named AI model was tested against a complete Cochrane Clinical Answer for this article. The worked example is original and fictional, while the comparison method explains what a genuine, reproducible evaluation would require.
What a Cochrane Clinical Answer is for
A clinician may need a concise answer without losing the route back to the underlying evidence. Cochrane's Clinical Answers introduction, published for a May 2026 event and checked on 26 September 2026, describes that question-centred, clinically oriented role.
The relationship to the review matters. A short answer should help a reader identify the relevant findings, but the underlying review remains important when methods, subgroups, outcome definitions or uncertainty affect the decision. A concise product is not a reason to stop asking whether the evidence fits the patient and setting.
Access also needs checking at the level of the actual resource. Being able to see a review abstract or plain-language summary does not establish access to the complete Clinical Answer or all underlying material. Use the Cochrane Clinical Answers information to identify the product and the access route available through your institution or subscription.
Compression has several different failure modes
An answer can omit information, alter its meaning, add an unsupported claim or preserve it with an appropriate qualification. These categories are more useful than a single judgement that the prose sounds clear.
Omission occurs when an important element disappears. For example, a short answer may name a benefit but omit the time period over which it was observed. Alteration occurs when "may improve" becomes "improves", or a comparison against usual care becomes a comparison against every available alternative.
An unsupported addition is different again. A summary might introduce a practical recommendation that the supplied evidence did not evaluate. The recommendation may sound plausible, but plausibility does not make it a faithful summary of that source.
Appropriate qualification preserves what remains uncertain without making the answer unreadable. The aim is not to append a generic warning to every sentence. It is to retain the limitations that materially affect interpretation.
An original fictional evidence card
Consider the educational question: does a structured follow-up conversation improve confidence after discharge compared with usual follow-up? The following evidence card is invented solely to demonstrate summary inspection. It is not a real Cochrane Review, a clinical recommendation or an observed AI output.
The fictional evidence concerns adults discharged after an uncomplicated episode of care. The intervention is a structured follow-up conversation; the comparator is the usual local arrangement. The assessed outcome is self-reported confidence at a short follow-up point. The example describes a small estimated improvement, with uncertainty about its size. It does not establish a reduction in readmission, and harms were not systematically assessed. The evidence does not address people with complex discharge needs.
Now consider two deliberately written summaries of that card. The first says: "Structured follow-up prevents readmission and should be offered to all discharged patients." This is concise, but it changes the population, invents an outcome and adds a recommendation.
The second says: "In this fictional evidence, a structured follow-up conversation may slightly improve short-term self-reported confidence after uncomplicated discharge compared with usual follow-up; effects on readmission, harms and more complex discharge situations remain unresolved."
The second is longer because it retains distinctions needed to understand the finding. Its advantage in this exercise is fidelity to the supplied card, not proof of superior clinical outcomes or evidence that a particular AI product behaves this way.
A summary-fidelity checklist
Use the following original checklist when comparing a concise answer with the evidence it claims to represent. Record the relevant source passage and the summary wording, rather than assigning a score from memory.
| Element | Question to ask | A meaningful discrepancy |
|---|---|---|
| Population | Who was actually studied? | A restricted group becomes all patients |
| Intervention | What was evaluated? | A particular programme becomes an entire treatment category |
| Comparator | What was it compared with? | Usual care becomes every possible alternative |
| Outcome | What was measured? | A surrogate or reported experience becomes a hard clinical outcome |
| Effect | How large was the estimated difference? | Direction is retained but magnitude is exaggerated |
| Time | Over what follow-up period? | A short-term finding becomes a lasting benefit |
| Harms | What was assessed and what was not? | No reported harm becomes proof of safety |
| Uncertainty | How secure and precise is the estimate? | A qualified finding becomes a definite conclusion |
| Applicability | Which limits affect this setting? | Missing populations or local differences disappear |
| Recommendation | Does the source actually support the proposed action? | Evidence synthesis becomes an instruction without explanation |
The Cochrane Handbook's interpretation chapter, checked on 26 September 2026, distinguishes the interpretation of effects and applicability from the additional judgements involved in decisions. The checklist applies that distinction to the practical task of reading a short answer.
How to run a fair comparison with an AI summary
Begin with a Clinical Answer and its underlying review that the evaluators can lawfully access. Record the title, version and access date. Write the shared clinical question before generating any AI output, so that the question is not adjusted to favour a result already seen.
Specify what evidence the AI receives. A source-constrained summary of supplied text tests a different capability from an open clinical query that can retrieve additional material. Both may be useful, but their results should not be mixed into one score. The first tests compression fidelity; the second also involves search, source selection and synthesis.
Record the product, model name and version where disclosed, test date, exact prompt, supplied material and relevant settings. If the model version is not disclosed, say so in the results rather than inventing one. Preserve the generated answer unchanged for assessment.
Ask evaluators to apply predefined discrepancy categories. Where feasible, remove branding during assessment and have more than one appropriately qualified reviewer examine clinically important disagreements. Distinguish a harmless wording difference from an omission that could change interpretation.
No results from that protocol are presented here because the required paired run was not performed. Results should be published only from an actual documented comparison, alongside the source set, outputs and method, rather than inferred from either product's marketing or from the fictional exercise above.
Keep source fidelity separate from being up to date
A summary can faithfully represent an older review while failing to answer a current clinical question. Conversely, a generated answer may mention newer evidence but misrepresent the review it cites. These are different problems and should be recorded separately.
For a current decision, check the review's search dates, subsequent updates and whether relevant newer research exists. A recent access date is not the same as a recent evidence search. Nor does adding the current year to a prompt establish that the answer incorporates the latest applicable guidance.
A useful evaluation therefore asks both whether the summary is faithful to its stated sources and whether those sources are sufficient for the intended question. Do not mark an answer better simply because it is longer or contains more citations. Additional material can improve coverage, introduce irrelevant findings or create unsupported apparent consensus.
When the short answer is not enough
Inspect the full review when the conclusion depends on a subgroup, a disputed outcome definition, a serious limitation or an effect estimate that is easy to misread. Seek relevant newer evidence when the review's search period leaves a consequential gap. Consult the applicable guideline when the question concerns what should be done within a particular clinical pathway rather than what a set of studies found.
Sometimes the right conclusion is that the available summary does not settle the decision. That is more useful than filling the gap with a confident recommendation that the evidence never established.
For teaching, use the discrepancy itself as the learning task. Ask the learner to explain why "harms were not systematically assessed" differs from "the intervention is safe", or why a change in confidence does not establish a change in readmission. These are transferable interpretation skills, not lessons about distrusting one brand.
Where iatroX should meet the same standard
Per iatroX product information, September 2026, Ask-iatroX provides source-linked clinical reference grounded in NICE, CKS, SIGN and SmPC information from emc, with retrieval, ranking, citation grounding, output checking and uncertainty handling described in its published methodology. These are system-design features, not proof that an answer has preserved every important qualification.
Readers should therefore inspect an iatroX answer using the same fidelity questions. Does the source support the particular claim? Has a population restriction disappeared? Is uncertainty visible? Does the answer distinguish evidence from the recommendation being discussed?
For a question already addressed by a suitable Cochrane Clinical Answer, its review-linked format may be a useful starting point. For a broader reference question, a conversational tool may help organise relevant guidance. For a high-consequence or methodologically disputed issue, neither short format should prevent deeper source inspection.
Frequently asked questions
Is a Cochrane Clinical Answer the same as a review's plain-language summary?
No: Cochrane describes Clinical Answers as a distinct question-centred clinical product linked to review evidence. Check which resource you are reading rather than treating every short Cochrane summary as interchangeable.
Did this article test a particular AI model against Cochrane?
No: it provides a reproducible comparison method and an explicitly fictional worked example. It does not present invented model outputs or comparative performance results.
What is the most important sign of a misleading short summary?
Look for a change in meaning, such as an uncertain finding becoming definite, an unmeasured outcome appearing as a benefit or a restricted population becoming everyone. Clear prose does not compensate for those changes.